Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development

被引:27
作者
Areschoug, T [1 ]
Carlsson, F [1 ]
Stålhammar-Carlemalm, M [1 ]
Lindahl, G [1 ]
机构
[1] Lund Univ, Dept Med Microbiol Dermatol & Infect, SE-22362 Lund, Sweden
关键词
group A streptococcus; puerperal fever; vaccines; C4b-binding protein; IgA-Fc;
D O I
10.1016/j.vaccine.2004.08.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Streptococcus pyogenes (group A streptococcus) causes a variety of diseases, including acute pharyngitis, impetigo, rheumatic fever and the streptococcal toxic shock syndrome. Moreover, S. pyogenes was responsible for the classical example of a nosocomial infection, the epidemics of puerperal fever (childbed fever) that caused the death of numerous women in earlier centuries. The most extensively studied virulence factor of S. pyogenes is the surface M protein, which inhibits phagocytosis and shows antigenic variation. Recent data indicate that many M proteins confer phagocytosis resistance because the variable N-terminal region has non-overlapping sites that specifically bind two components of the human immune system, the complement inhibitor C4b-binding protein (C4BP) and IgA-Fc. Concerning puerperal fever, molecular and epidemiological analysis suggests that the S. pyogenes surface protein R28 may have played a pathogenetic role in these epidemics. This article summarizes the properties of M protein and the R28 protein and considers a potential problem encountered in connection with the use of animal models for vaccine development. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S9 / S14
页数:6
相关论文
共 46 条
  • [1] Accardo P, 1996, J IMMUNOL, V157, P4935
  • [2] EPIDEMIC SPREAD AND ANTIGENIC VARIABILITY OF NEISSERIA-MENINGITIDIS
    ACHTMAN, M
    [J]. TRENDS IN MICROBIOLOGY, 1995, 3 (05) : 186 - 192
  • [3] Areschoug T, 1999, INFECT IMMUN, V67, P6350
  • [4] Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection
    Ashbaugh, CD
    Moser, TJ
    Shearer, MH
    White, GL
    Kennedy, RC
    Wessels, MR
    [J]. CELLULAR MICROBIOLOGY, 2000, 2 (04) : 283 - 292
  • [5] Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection
    Ashbaugh, CD
    Warren, HB
    Carey, VJ
    Wessels, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) : 550 - 560
  • [6] Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8-and diphtheria toxoid-specific antibodies to protection
    Batzloff, MR
    Hayman, WA
    Davies, MR
    Zeng, M
    Pruksakorn, S
    Brandt, ER
    Good, MF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) : 1598 - 1608
  • [7] Binding of human C4BP to the hypervariable region of M protein:: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes
    Berggård, K
    Johnsson, E
    Morfeldt, E
    Persson, J
    Stålhammar-Carlemalm, M
    Lindahl, G
    [J]. MOLECULAR MICROBIOLOGY, 2001, 42 (02) : 539 - 551
  • [8] BESSEN D, 1990, J IMMUNOL, V145, P1251
  • [9] Brown EJ, 1998, IMMUNOL MED, V26, P141
  • [10] Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein
    Carlsson, F
    Berggård, K
    Stålhammar-Carlemalm, M
    Lindahl, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) : 1057 - 1068